EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieKohortenstudie

Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study

Claudia A Bargon iD, Dieuwke R Mink van der Molen iD, Danny A Young-Afat iD, Marilot C T Batenburg iD, Iris E van Dam iD, Inge O Baas iD, Miranda F Ernst, Wiesje Maarse iD, Maartje F Sier, Ernst J P Schoenmaeckers iD, Josephina P J Burgmans iD, Rhodé M Bijlsma iD und 7 weitere

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djae310 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Claudia A Bargon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre, 3584 CX Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammaplasty, Mastectomy, Segmental, Patient Reported Outcome Measures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: St Antonius Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oncoplastic breast-conserving surgery (OP-BCS) is becoming increasingly popular to avoid mastectomy or optimize cosmetic outcomes of breast-conserving surgery (BCS). Few studies have compared clinical outcomes and patient-reported outcomes (PROs) of OP-BCS to conventional BCS (C-BCS). This study aims to compare clinical outcomes and short- and long-term PROs after OP-BCS and C-BCS in a large prospective breast cancer cohort.

Methods

Women in the prospective, multicenter UMBRELLA (Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion) breast cancer cohort who underwent OP-BCS or C-BCS were included. Clinical outcomes and PROs (measured by EORTC QLQ-C30/BR23) up to 24 months postoperatively were evaluated. Mixed-model analysis was performed to assess differences in PROs over time between groups.

Results

A total of 1628 (84.9%) patients received C-BCS and 290 (15.1%) received OP-BCS. After C-BCS and OP-BCS, free resection margins were obtained in 84.2% (n = 1370) and 86.2% (n = 250), respectively, reoperation for re-excision of margins within 3 months occurred in 5.3% (n = 86) and 4.8% (n = 14), and the median time interval from surgery until adjuvant systemic therapy was 66 and 63 days, and 36 and 41 days until radiotherapy. Shortly postoperative, OP-BCS was associated with statistically significant lower mean scores for physical functioning (83.6 vs 87.2) and body image (82.8 vs 89.4) and more pain (19.8 vs 26.5) and breast symptoms (22.7 vs 30.3) than C-BCS. Body image scores remained statistically significantly less favorable after OP-BSC than C-BCS up to 24 months postoperatively (87.8 vs 92.2).

Conclusions

Oncoplastic surgery safely enables BCS but may lead to less favorable long-term body image compared to C-BCS. These findings are important for patient education and shared decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMammaplastyMastectomy, SegmentalPatient Reported Outcome MeasuresAdultAgedAged, 80 and overFemaleHumansMiddle AgedYoung AdultLongitudinal StudiesMargins of ExcisionProspective StudiesQuality of LifeReoperationTreatment Outcome

Autor:innen und Institutionen

  • Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre, 3584 CX Utrecht, The Netherlands.
  • Department of Surgery, St Antonius Hospital, 3543 AZ Utrecht, The Netherlands.
  • Department of Plastic, Reconstructive and Hand Surgery, Amsterdam University Medical Centre, 1105 AZ Amsterdam, The Netherlands.
  • Department of Radiation Oncology, University Medical Centre Utrecht, Cancer Centre, 3584 CX Utrecht, The Netherlands.
  • Department of Medical Oncology, University Medical Centre Utrecht, Cancer Centre, 3584 CX Utrecht, The Netherlands.
  • Department of Surgery, Alexander Monro Clinics, 3723 MB Bilthoven, The Netherlands.

ORCID-Profile: Claudia A Bargon, Dieuwke R Mink van der Molen, Danny A Young-Afat, Marilot C T Batenburg, Iris E van Dam, Inge O Baas, Wiesje Maarse, Ernst J P Schoenmaeckers, Josephina P J Burgmans, Rhodé M Bijlsma, Sabine Siesling, Hinne A Rakhorst, Marc A M Mureau

Förderung

  • St Antonius Hospital Research Fund

Zitieren

APA

Bargon, C. A., Mink van der Molen, D. R., Young-Afat, D. A., Batenburg, M. C. T., van Dam, I. E., Baas, I. O., Ernst, M. F., Maarse, W., Sier, M. F., Schoenmaeckers, E. J. P., Burgmans, J. P. J., Bijlsma, R. M., Siesling, S., Rakhorst, H. A., Mureau, M. A. M., van der Leij, F., Doeksen, A., Verkooijen, H. M., & UMBRELLA Study Group (2025). Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae310

Vancouver

Bargon CA, Mink van der Molen DR, Young-Afat DA, Batenburg MCT, van Dam IE, Baas IO, et al. Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae310

BibTeX
@article{Bargon2025,
  author = {Bargon, Claudia A and Mink van der Molen, Dieuwke R and Young-Afat, Danny A and Batenburg, Marilot C T and van Dam, Iris E and Baas, Inge O and Ernst, Miranda F and Maarse, Wiesje and Sier, Maartje F and Schoenmaeckers, Ernst J P and Burgmans, Josephina P J and Bijlsma, Rhodé M and Siesling, Sabine and Rakhorst, Hinne A and Mureau, Marc A M and van der Leij, Femke and Doeksen, Annemiek and Verkooijen, Helena M and UMBRELLA Study Group, UMBRELLA Study Group},
  title = {Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djae310}
}
Kostenlos starten →